FdaApplication
ANDA 203246
Identifiers
- fda_app_no: ANDA203246
Properties
| Property | Value |
|---|---|
| applicant_name | UNIV TEXAS MD ANDERSON CANCER CENTER |
| application_type | ANDA |
| approval_date | 2014-01-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | 20-150mCi/ML | INJECTABLE;INTRAVENOUS |
| FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | 20-300mCi/ML | INJECTABLE;INTRAVENOUS |
2 products